Internal Medicine, Rheumatology · Waukesha, WI
NPI
1275670275
Since 2007
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
20800 Swenson Dr Ste 175
Waukesha, WI, 53186
Phone (262) 785-1964
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.3M
110,982 services
Medicare patients, 2024
498
Average age 73
Drug cost, 2024
$3.8M
5,631 prescriptions
Company payments, 2025
$252
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Carly L Skamra was code J3262 (injection, tocilizumab, 1 mg), 34,650 times for 14 patients. In total Carly L Skamra billed 110,982 services in 64 codes, and Medicare paid $1.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3262 Injection, tocilizumab, 1 mg | Office | 34,650 | 14 | $4.71 | $163K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 32,176 | 69 | $9.14 | $294K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 9,625 | 25 | $33.84 | $326K |
| J0897 Injection, denosumab, 1 mg | Office | 3,300 | 29 | $20.33 | $67K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 2,880 | 16 | $24.01 | $69K |
| J9312 Injection, rituximab, 10 mg | Office | 2,350 | 11 | $61.37 | $144K |
| 36415 Venipuncture Blood Collection | Office | 974 | 393 | $8.56 | $8,335 |
| 85025 Blood Count | Office | 896 | 350 | $7.55 | $6,761 |
| 84450 Clinical Chemistry | Office | 880 | 348 | $5.04 | $4,432 |
| 82040 Clinical Chemistry | Office | 880 | 348 | $4.81 | $4,231 |
| 82565 Clinical Chemistry | Office | 880 | 347 | $4.98 | $4,379 |
| 84460 Clinical Chemistry | Office | 877 | 348 | $5.16 | $4,521 |
| 99214 Office E&M - Established | Office | 724 | 360 | $83.52 | $60K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 633 | 366 | $11.20 | $7,092 |
| 85652 Clinical Chemistry | Office | 567 | 337 | $2.65 | $1,504 |
By year: 2022 $727K for 53,442 services; 2023 $1.0M for 85,264 services; 2024 $1.3M for 110,982 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 974 | 393 | $8.56 | $8,335 |
| 85025 Blood Count | 896 | 350 | $7.55 | $6,761 |
| 84450 Clinical Chemistry | 880 | 348 | $5.04 | $4,432 |
| 82040 Clinical Chemistry | 880 | 348 | $4.81 | $4,231 |
| 82565 Clinical Chemistry | 880 | 347 | $4.98 | $4,379 |
| 84460 Clinical Chemistry | 877 | 348 | $5.16 | $4,521 |
| 85652 Clinical Chemistry | 567 | 337 | $2.65 | $1,504 |
| 86140 Clinical Chemistry | 565 | 336 | $5.05 | $2,855 |
| 82784 Immunoassay | 281 | 83 | $8.98 | $2,524 |
| 86235 Immunoassay | 162 | 24 | $17.15 | $2,778 |
Medicare prescription drug claims, 2024
In 2024, the drug Carly L Skamra prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 1,068 prescriptions and refills. In total Carly L Skamra wrote 5,631 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 1,068 | 2,715 | 279 | $27K |
| Hydroxychloroquine Sulfate Generic | 933 | 2,537 | 264 | $41K |
| Prednisone Generic | 336 | 501 | 109 | $2,076 |
| Folic Acid Generic | 315 | 929 | 90 | $4,085 |
| Tramadol Hcl Generic | 223 | 233 | 51 | $1,419 |
| Meloxicam Generic | 189 | 445 | 62 | $1,120 |
| Allopurinol Generic | 187 | 525 | 51 | $1,661 |
| Leflunomide Generic | 179 | 460 | 49 | $14K |
| Humira(Cf) Pen Adalimumab | 177 | 196 | 18 | $1.4M |
| Colchicine Generic | 168 | 374 | 47 | $24K |
| Alendronate Sodium Generic | 167 | 438 | 53 | $1,009 |
| Celecoxib Generic | 136 | 307 | 48 | $6,982 |
| Duloxetine Hcl Generic | 133 | 360 | 38 | $4,469 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 103 | 103 | 15 | $2,416 |
| Gabapentin Generic | 74 | 144 | 17 | $1,690 |
Brand drugs: 703 claims; generic drugs: 4,906 claims; opioid claims: 347.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Carly L Skamra $252 ($252 in general payments such as food, travel and fees) from 5 companies. The largest payer was Abbvie Inc. with $146.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.